ADBIOTECH Co.,Ltd. Q3 revenue KRW 7.2 billion, operating loss KRW 1.2 billion
AI summary · Not investment advice
In Q3, the company sold KRW 7.2 billion worth and lost KRW 1.2 billion from its main business; sales rose 97.3% from a year earlier and 146.3% from the prior quarter.
Operating profit · 3 months
KRW -1.2 billion
Key facts
- Revenue (3 months)
- KRW 7.2 billion
- Net income (3 months)
- KRW -1.9 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 3.6 billion
- Revenue (year to date)
- KRW 13.1 billion
- Operating profit (prior-year 3 months)
- KRW -1.8 billion
- Operating profit (year to date)
- KRW -4.2 billion
- Net income (prior-year 3 months)
- KRW -4.8 billion
- Net income (year to date)
- KRW -7.6 billion
Commentary
AI commentary · Not investment advice
What happened
Advbiotech reported its consolidated results for the 3rd quarter of 2026. Sales for the 3 months were KRW 7.15 billion. That is 97.3% higher than the same 3 months a year earlier, which had KRW 3.63 billion. It is also 146.3% higher than the previous quarter. Cumulative sales for the year are KRW 13.13 billion.
In the company's terms
Operating profit (profit from the core business) for the 3 months was a loss of KRW 1.16 billion. In the same period a year earlier, the operating loss was KRW 1.76 billion. The cumulative operating loss for the year is KRW 4.16 billion.
What changes for shareholders
Net income (the final profit after taxes and all other items) for the 3 months was a loss of KRW 1.93 billion. A year earlier, the net loss for the same period was KRW 4.81 billion. The cumulative net loss for the year is KRW 7.62 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
A